Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2009, 77(Posters (PO)), 224; https://doi.org/10.3797/scipharm.oephg.21.PO-25 (registering DOI)
Synthesis of Deuterated Analogs of Honokiol
Institute of Pharm. Sciences, Dept. of Pharm. Chemistry, University of Graz, Universitätsplatz 1, 8010 Graz, Austria
Institute of Pharm. Sciences, Dept. of Pharmacognosy, University of Graz, Universitätsplatz 4, 8010 Graz, Austria
Author to whom correspondence should be addressed.
Received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Abstract The genus Magnolia plays a role in American as well as in Asian medicinal systems such as TCM or Japanese Kampo medicine [1, 2]. Main lignan constituents in the seeds of the north american Magnolia grandiflora are honokiol (1) and 4'-O-methyl-honokiol. They are known to possess anti-inflammatory activities with COX-2 inhibitory activity (IC50) of about 0.1 to 3 μM.
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
HÜFNER, A.; SCHÜHLY, W. Synthesis of Deuterated Analogs of Honokiol. Sci. Pharm. 2009, 77, 224.
HÜFNER A, SCHÜHLY W. Synthesis of Deuterated Analogs of Honokiol. Scientia Pharmaceutica. 2009; 77(Posters (PO)):224.
HÜFNER, A.; SCHÜHLY, W. 2009. "Synthesis of Deuterated Analogs of Honokiol." Sci. Pharm. 77, Posters (PO): 224.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.